Literature DB >> 9753136

VIP and PACAP potentiate the action of glutamate on BDNF expression in mouse cortical neurones.

G Pellegri1, P J Magistretti, J L Martin.   

Abstract

In view of the neurotrophic effect of vasoactive intestinal peptide (VIP), the regulation of brain-derived neurotrophic factor (BDNF) expression by VIP and the related peptide pituitary adenylate cyclase-activating polypeptide (PACAP) was analysed by Northern blot in primary cultures of cortical neurones. Results reported in this article demonstrate that VIP and PACAP stimulate the expression of BDNF mRNA in primary cultures of cortical neurones and astrocytes. In primary cultures of cortical neurones, induction of BDNF mRNA by VIP and PACAP is completely inhibited by the N-methyl-D-aspartate (NMDA) receptor antagonists MK-801 and AP5, therefore indicating that VIP and PACAP do not stimulate BDNF expression directly but rather by potentiating the effect of glutamate tonically released by neurones and acting at NMDA receptors. In addition to its neurotrophic effects, BDNF has been shown to be involved in neuronal plasticity and results reported here suggest that by stimulating BDNF expression, VIP and PACAP could modulate synaptic plasticity in the cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753136     DOI: 10.1046/j.1460-9568.1998.00052.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  26 in total

1.  Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons.

Authors:  Karen M Braas; Kristin C Schutz; Jeffrey P Bond; Margaret A Vizzard; Beatrice M Girard; Victor May
Journal:  Peptides       Date:  2007-04-19       Impact factor: 3.750

Review 2.  Neurotrophins in the Brain: Interaction With Alcohol Exposure During Development.

Authors:  K E Boschen; A Y Klintsova
Journal:  Vitam Horm       Date:  2016-11-29       Impact factor: 3.421

3.  Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease.

Authors:  Orhan Tansel Korkmaz; Hakan Ay; Nurgul Aytan; Isabel Carreras; Neil W Kowall; Alpaslan Dedeoglu; Nese Tuncel
Journal:  J Mol Neurosci       Date:  2018-11-29       Impact factor: 3.444

4.  Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism.

Authors:  M Figiel; J Engele
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 5.  A new concept in the pharmacology of neuroprotection.

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

6.  Late-stage immature neocortical neurons reconstruct interhemispheric connections and form synaptic contacts with increased efficiency in adult mouse cortex undergoing targeted neurodegeneration.

Authors:  Rosemary A Fricker-Gates; Jennifer J Shin; Cindy C Tai; Lisa A Catapano; Jeffrey D Macklis
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

7.  Pituitary adenylate cyclase-activating polypeptide regulates brain-derived neurotrophic factor exon IV expression through the VPAC1 receptor in the amphibian melanotrope cell.

Authors:  Adhanet H Kidane; Eric W Roubos; Bruce G Jenks
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

8.  Pituitary adenylate cyclase-activating polypeptide: Postnatal development in multiple brain stem respiratory-related nuclei in the rat.

Authors:  Qiuli Liu; Margaret T T Wong-Riley
Journal:  Respir Physiol Neurobiol       Date:  2018-10-22       Impact factor: 1.931

Review 9.  Role of PACAP in ischemic neural death.

Authors:  Hirokazu Ohtaki; Tomoya Nakamachi; Kenji Dohi; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2008-05-16       Impact factor: 3.444

10.  Transduction of PACAP38 protects primary cortical neurons from neurotoxic injury.

Authors:  Alma Sanchez; Maurizo Chiriva-Internati; Paula Grammas
Journal:  Neurosci Lett       Date:  2008-10-14       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.